Zurcher Kantonalbank (Zurich Cantonalbank) Day One Biopharmaceuticals, Inc. Transaction History
Zurcher Kantonalbank (Zurich Cantonalbank)
- $39 Billion
- Q2 2025
A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 32,939 shares of DAWN stock, worth $261,865. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32,939
Previous 14,269
130.84%
Holding current value
$261,865
Previous $113,000
89.38%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding DAWN
# of Institutions
188Shares Held
69.3MCall Options Held
127KPut Options Held
85.5K-
Atlas Venture Life Science Advisors, LLC6.43MShares$51.1 Million9.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.18MShares$49.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.53MShares$36 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA4.1MShares$32.6 Million0.01% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.72MShares$29.6 Million0.56% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $584M
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...